产品封面图

FITC标记的晚期糖基化终末产物特异性受体抗体

收藏
  • ¥2980
  • LMAI Bio
  • LM-0177R-FITC
  • 中国/美国/欧洲
  • 2025年07月13日
  • Flow-Cyt=1:50-200 ICC=1:50-200 IF=1:50-200
  • Human, Mouse, Rat,
  • Human, Mouse, Rat,
avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 供应商

      上海联迈生物工程有限公司

    • 库存

      大量

    • 靶点

      详见说明书

    • 级别

      1

    • 目录编号

      LM-0177R-FITC

    • 克隆性

      多克隆

    • 抗原来源

      Rabbit

    • 保质期

      1年

    • 抗体英文名

      Anti-RAGE/FITC

    • 抗体名

      Anti-RAGE/FITC

    • 标记物

      FITC标记

    • 宿主

      Human, Mouse, Rat,

    • 适应物种

      Human, Mouse, Rat,

    • 免疫原

      详见说明书

    • 亚型

      IGg

    • 形态

      粉末、液体、冻干粉

    • 应用范围

      Flow-Cyt=1:50-200 ICC=1:50-200 IF=1:50-200

    • 浓度

      1mg/ml

    • 保存条件

      -20 °C

    • 规格

      100ul

    FITC标记的晚期糖基化终末产物特异性受体抗体
    英文名称 Anti-RAGE/FITC
    中文名称 FITC标记的晚期糖基化终末产物特异性受体抗体
    别    名 Advanced glycosylation end product specific receptor; Advanced glycosylation end product-specific receptor; AGER; EC 2.7.11.22; LE 9211 A antigen;LE-9211-A antigen; MGC22357; MOK; RAGE 1; RAGE1; MOK protein kinase; Receptor for advanced glycation endproducts;Renal tumor antigen 1; Renal tumor antigen; Renal cell carcinoma antigen (MOK protein kinase); Renal tumor antigen 1; RAGE_HUMAN.  
    产品细节图片1 Journal
    PMID
    IF
    Application
    Mediators of Inflammation (2014)
    Others
    3.8820
    FCM
    Acta Pharmacologica Sinica (2014)
    25152026
    2.4960
    FCM
    规格价格 100ul/2980元 购买        大包装/询价
    说 明 书 100ul  
    研究领域 肿瘤  心血管  免疫学  生长因子和激素  糖尿病  内分泌病  
    抗体来源 Rabbit
    克隆类型 Polyclonal
    交叉反应 Human, Mouse, Rat, 
    产品应用 Flow-Cyt=1:50-200 ICC=1:50-200 IF=1:50-200  
    not yet tested in other applications.
    optimal dilutions/concentrations should be determined by the end user.
    分 子 量 42kDa
    细胞定位 细胞膜 
    性    状 Lyophilized or Liquid
    浓    度 1mg/ml
    免 疫 原 KLH conjugated synthetic peptide derived from rat AGER
    亚    型 IgG
    纯化方法 affinity purified by Protein A
    储 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
    保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
    产品介绍 background:
    Advanced glycosylation end product-specific receptor (AGER; RAGE) is a member of the immunoglobulin superfamily of cell surface molecules that binds molecules that have been irreversibly modified by non-enzymatic glycation and oxidation, and are know as advanced glycation end products (AGEs). It is expressed by endothelium, mononuclear phagocytes, neurons and smooth muscle cells. Whereas RAGE is present at high levels during development, especially in the central nervous system, its levels decline during maturity.The increased expression of RAGE is associated with several pathological states, such as diabetic vasculopathy, neuropathy, retinopathy and other disorders, including Alzheimer's disease and immune/inflammatory reactions of the vessel walls. In diabetic tissues, the production of RAGE is due to the overproduction of AGEs that eventually overwhelm the protective properties of RAGE. This results in oxidative stress and endothelial cell dysfunction that leads to vascular disease in diabetics. In the brain, RAGE also binds amyloid beta (Ab). Because Ab is overproduced in neurons and vessels in the brains of Alzheimer disease, this leads to the hyperstimulation of RAGE. The RAGE-Ab interaction is thought to result in oxidative stress leading to neuronal degeneration. 

    Function:
    Mediates interactions of advanced glycosylation end products (AGE). These are nonenzymatically glycosylated proteins which accumulate in vascular tissue in aging and at an accelerated rate in diabetes. Acts as a mediator of both acute and chronic vascular inflammation in conditions such as atherosclerosis and in particular as a complication of diabetes. AGE/RAGE signaling plays an important role in regulating the production/expression of TNF-alpha, oxidative stress, and endothelial dysfunction in type 2 diabetes. Interaction with S100A12 on endothelium, mononuclear phagocytes, and lymphocytes triggers cellular activation, with generation of key proinflammatory mediators. Receptor for amyloid beta peptide. Contributes to the translocation of amyloid-beta peptide (ABPP) across the cell membrane from the extracellular to the intracellular space in cortical neurons. ABPP-initiated RAGE signaling, especially stimulation of p38 mitogen-activated protein kinase (MAPK), has the capacity to drive a transport system delivering ABPP as a complex with RAGE to the intraneuronal space. Interaction with S100B after myocardial infarction may play a role in myocyte apoptosis by activating ERK1/2 and p53/TP53 signaling.

    Subunit:
    Interacts with S100B, S100A1 and APP. Interacts with S100A12.

    Subcellular Location:
    Isoform 1: Cell membrane; Single-pass type I membrane protein.
    Isoform 2: Secreted.

    Tissue Specificity:
    Endothelial cells and cardiomyocytes.

    Similarity:
    Contains 2 Ig-like C2-type (immunoglobulin-like) domains.
    Contains 1 Ig-like V-type (immunoglobulin-like) domain.

    Database links:

    Entrez Gene: 177 Human

    Entrez Gene: 11596 Mouse

    Entrez Gene: 81722 Rat

    Omim: 600214 Human

    SwissProt: Q15109 Human

    SwissProt: Q62151 Mouse

    SwissProt: Q63495 Rat

    Unigene: 534342 Human

    Unigene: 3383 Mouse

    Unigene: 9829 Rat



    Important Note:
    This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

    晚期糖基化终末产物受体(AGER)与其配体AGEs形成的AGEs-AGER 系统在糖尿病血管病变的发生、发展过程中起着重要作用.
    年龄及晚期糖基化终末产物(AGEs)等多种因素均能调节AGER基因的表达. 糖尿病患者体内晚期糖基化终末产物受体(AGER)的高表达加速了病人血管病变的发展过程,并增加了病变的复杂性.阻断AGER通路可缓解糖尿病血管的病变过程。
    因此,AGER可以作为治疗糖尿病血管病变的药物靶点,并为临床治疗糖尿病血管病变提供了新的思路.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • 大鼠晚期糖基化终末产物(AGEs)酶联免疫分析

      (AGEs) , 与 HRP 标记晚期糖基化终末产物 (AGEs) 抗体结合,形成抗体 - 抗原 - 酶标抗体复合物,经过彻底洗涤后加底物 TMB 显色。 TMB 在 HRP 酶的催化下转化成蓝色,并在酸的作用下转化成最终的黄色。颜色的深浅和样品中的晚期糖基化终末产物 (AGEs) 呈正相关。用酶标仪在 450nm 波长下测定吸光度( OD 值),通过标准曲线计算样品中大鼠晚期糖基化终末产物 (AGEs) 浓度。   试剂盒组成

    • 人可溶性晚期糖基化终末产物受体(sRAGE)酶联免疫分析(ELISA)

      板,制成固相抗体,往包被单抗的微孔中依次加入 可溶性晚期糖基化终末产物受体 (sRAGE) ,再与 HRP 标记的羊抗人抗体结合,形成抗体 - 抗原 - 酶标抗体复合物,经过彻底洗涤后加底物 TMB 显色。 TMB 在 HRP 酶的催化下转化成蓝色,并在酸的作用下转化成最终的黄色。颜色的深浅和样品中的 可溶性晚期糖基化终末产物受体 (sRAGE) 呈正相关。用酶标仪在 450nm 波长下测定吸光度( OD 值),通过标准曲线计算样品中 人可溶性晚期糖基化终末产物受体 (sRAGE) 含量

    • 磷脂酰丝氨酸外翻分析(Annexin V法)

      磷脂酰丝氨酸(Phosphatidylserine, PS)正常位于细胞膜的内侧,但在细胞凋亡的早期,PS可从细胞膜的内侧翻转到细胞膜的表面,暴露在细胞外环境中(图3)。Annexin-V是一种分子量为35~36KD的Ca2+依赖性磷脂结合蛋白,能与PS高亲和力特异性结合。将Annexin-V进行荧光素(FITC、PE)或biotin标记,以标记了的Annexin-V作为荧光探针,利用流式细胞仪或荧光显微镜可检测细胞凋亡的发生。碘化丙啶(propidine iodide, PI)是一种核酸

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    上海圻明生物科技有限公司
    2025年07月13日询价
    ¥1660
    上海沪震实业有限公司
    2025年07月09日询价
    ¥600
    北京百奥莱博科技有限公司
    2025年10月16日询价
    询价
    上海钰博生物科技有限公司
    2025年07月16日询价
    询价
    上海邦景实业有限公司
    2025年07月15日询价
    FITC标记的晚期糖基化终末产物特异性受体抗体
    ¥2980